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O6-methylguanine (O6meG) and related modifications of guanine in
double-stranded DNA are functionally severe lesions that can be
produced by many alkylating agents, including N-methyl-N-nitro-N-
nitrosoguanidine (MNNG), a potent carcinogen. O6meG is repaired
through its demethylation by the O6-alkylguanine-DNA alkyltrans-
ferase (AGT). This protein is calledMgmt (or MGMT) in mammals and
Mgt1 in the yeast Saccharomyces cerevisiae. AGT proteins remove
methyl and other alkyl groups from an alkylated O6 in guanine by
transferring the adduct to an active-site cysteine residue. The result-
ing S-alkyl-Cys of AGT is not restored back to Cys, so repair proteins
of this kind can act only once. We report here that S. cerevisiaeMgt1
is cotargeted for degradation, through a degron near its N terminus,
by 2 ubiquitin-mediated proteolytic systems, the Ubr1/Rad6-depen-
dent N-end rule pathway and the Ufd4/Ubc4-dependent ubiquitin
fusion degradation (UFD) pathway. The cotargeting ofMgt1 by these
pathways is synergistic, in that it increases not only the yield of
polyubiquitylated Mgt1, but also the processivity of polyubiquityla-
tion. The N-end rule and UFD pathways comediate both the consti-
tutive and MNNG-accelerated degradation of Mgt1. Yeast cells lack-
ing theUbr1 andUfd4ubiquitin ligaseswere hyperresistant toMNNG
but hypersensitive to the toxicity of overexpressed Mgt1. We con-
sider ramifications of this discovery for the control of DNA repair and
mechanisms of substrate targeting by the ubiquitin system.
N-end rule  proteolysis  Ubr1  Ufd4  yeast
S ince the 1987 discovery that a key DNA repair protein, Rad6,was a ubiquitin (Ub)-conjugating enzyme (1, 2), there have
been great strides in understanding the massive, multilevel involve-
ment of the Ub–proteasome system in the DNA damage response
(reviewed in refs. 3 and 4). A major aspect of this response is the
repair of damage caused by alkylating agents such as N-methyl-N-
nitro-N-nitrosoguanidine (MNNG) and methyl methane sulfonate
(MMS), which produce both mutagenic and cytotoxic lesions in
DNA (4, 5). One functionally severe lesion in double-stranded
DNA is O6-methylguanine (O6meG), which is demethylated by the
O6-alkylguanine-DNA alkyltransferase (AGT). This protein is
called Mgmt (or MGMT) in mammals and Mgt1 in the yeast
Saccharomyces cerevisiae (5–8). Compounds that produce O6meG
in DNA are common environmental carcinogens. Some of these
compounds are also formed as a part of normal cellular metabo-
lism. The repair of O6meG in DNA is down-regulated in many
cancers, usually because of lower than normal levels of Mgmt in
cancer cells. Consequently, some anticancer drugs are DNA alky-
lating agents whose targets include O6 in guanine. An acquired or
preexisting resistance of cancer cells to such drugs often involves an
up-regulation of Mgmt (4, 5). AGT proteins remove methyl and
other alkyl groups from alkylated O6 in guanine by transferring an
adduct to an active-site Cys residue (5, 6). The resulting S-alkyl-Cys
residue ofAGT is not restored back toCys, so repair proteins of this
kind can act only once. In mammals, the alkylated (inactive) Mgmt
and possibly the unmodified Mgmt are short-lived proteins, de-
graded by an unknown pathway (9). In human cells that express the
E6 protein of the human papilloma virus (HPV), MGMT is also
targeted for degradation by a complex of the viral E6 protein and
E6AP, one of mammalian HECT-domain E3 Ub ligases (8, 10).
In this study, we discovered that Mgt1, the O6meG-DNA alky-
ltransferase of S. cerevisiae, is a physiological substrate of both the
Ubr1-dependent N-end rule pathway and the Ufd4-dependent Ub
fusion degradation (UFD) pathway (Fig. 1). S. cerevisiaeMgt1 is a
188-residue protein that is sequelogous (similar in sequence) (11)
to mammalian Mgmt (7, 12, 13).
The N-end rule relates the in vivo half-life of a protein to the
identity of its N-terminal residue (2, 14–17). Degradation signals
(degrons) that are targeted by the N-end rule pathway include a set
called N-degrons (2, 15). The main determinant of an N-degron is
a destabilizingN-terminal residue of a substrate protein. TheN-end
rule has a hierarchic structure that involves the primary, secondary,
and tertiary destabilizing N-terminal residues (Fig. 1A). Destabi-
lizing activities of these residues differ by their requirements for a
preliminary enzymatic modification (refs. 2 and 15–18 and refer-
ences therein). E3 Ub ligases of the N-end rule pathway are called
N-recognins (15, 17, 19–21). They bind to primary destabilizing
N-terminal residues of N-end rule substrates. The S. cerevisiae N-end
rule pathway contains a single N-recognin, Ubr1, a 225-kDa
sequelog (11) ofmammalianUbr1 andUbr2 (Fig. 1A) (19–23). The
functions of the N-end rule pathway (Fig. 1A) include the sensing
of nitric oxide (NO), oxygen, heme, and short peptides; the
maintenance of the high fidelity of chromosome segregation; the
control of peptide import; regulation of signaling by transmem-
brane receptors, through the NO/O2-dependent degradation of
regulators of G protein signaling (RGS) proteins that down-
regulate G proteins; specific functions of the pancreas; regulation
of apoptosis, meiosis, spermatogenesis, neurogenesis, and cardio-
vascular development in mammals; and regulation of leaf senes-
cence in plants (refs. 2, 17, 18, and 21–25 and references therein).
TheUFDpathway was discovered through the use of engineered
Ub fusions in which the structure of either the N-terminal Ub
moiety or its junction with a downstream polypeptide inhibited the
cleavage of a Ub fusion by deubiquitylating enzymes (DUBs) (14,
26, 27). Genetic dissection of the UFD pathway in S. cerevisiae
identified Ufd1–Ufd5 as proteins that were required, either strictly
or in part, for the degradation of engineered UFD substrates (27,
28). Ufd4 is the 168-kDa HECT-domain E3 enzyme of the UFD
pathway, which functions together with the E2 enzymes Ubc4 or
Ubc5. Distinct domains of Ufd4 were shown to recognize the
N-terminal Ub moiety of UFD substrates (29) and also specific
subunits of the 26S proteasome (30, 31). Ufd4 plays a role in the
conditional autoubiquitylation and degradation of the Ubc7 E2
enzyme (32). Rad4, a nucleotide excision repair protein, is partially
stabilized in ufd4 cells, suggesting that Rad4 may be a substrate of
the UFD pathway (33).
Besides its relevance to DNA repair, the identification of S.
cerevisiae Mgt1 DNA alkyltransferase as a physiological sub-
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strate of both the N-end rule and UFD pathways (Fig. 1) brings
together 2 mechanistically distinct targeting systems, in that
Ubr1 is a RING-type E3, whereas Ufd4 is a HECT-type E3. The
N-end rule and UFD pathways were the first specific pathways
of the Ub system to be discovered (14). Studies of these pathways
have been proceeding largely in parallel (2, 14, 15, 26–29, 31, 33),
until the present discovery of their functional and mechanistic
connection, as described below.
Results and Discussion
N-End Rule Pathway Targets Mgt1 for Degradation. Large-scale
identification of S. cerevisiae protein complexes through coimmu-
noprecipitation and other assays suggested that the 225-kDa Ubr1
E3 Ub ligase (Fig. 1A) may physically interact with Ygl081w, Pex7,
Yak1,Mgt1, Ccr4,Gal80, and Srs2 [see supporting information (SI)
Materials andMethods and the legend to Fig. S1].We askedwhether
any of these putative Ubr1 ligands were short-lived in vivo, and, if
so, whether they were degraded at least in part by the N-end rule
pathway. We used a ‘‘cycloheximide-chase’’ assay with wild type
(wt) versus ubr1 S. cerevisiae. In this method, the in vivo levels of
a protein of interest are determined by SDS/PAGE and immuno-
blotting (IB) of cell extracts as a function of time after the inhibition
of translation by cycloheximide. A majority of the above proteins
were found to metabolically unstable. However, the absence of
Ubr1 stabilized just one of these proteins,Mgt1 (Fig. S1A), the sole
O6-methylguanine DNA-alkyltransferase in S. cerevisiae (see
Introduction).
Although the inferred ORF of S. cerevisiae Mgt1 contains 2
in-frame start codons, 18 codons apart (7), only the smaller,
188-residue Mgt1 is produced in vivo (13). We replaced the
chromosomal MGT1 gene with an otherwise identical ORF ex-
pressing Mgt1m13 (C-terminally tagged with 13 copies of the 10-
residue myc epitope) from the endogenous PMGT1 promoter.
Mgt1m13 was indistinguishable from wt MGT1 in its ability to
protect cells fromMNNG, a DNA-alkylating agent (Fig. S1C). The
instability ofMgt1m13 could be restored by reintroducingUBR1 into
ubr1 cells (Fig. 2A). Importantly, this rescue did not occur with
Ubr1C1220S, an inactive Ubr1 mutant (20) (Fig. 2A).
A cycloheximide-chase assay monitors the in vivo decay of both
‘‘young’’ and ‘‘old’’ molecules of a test protein. To assess the
metabolic fate of newly formed Mgt1, we carried out pulse–chase
assays with fDHFR-UbK48R-Mgt1f [‘‘f’’ denotes the flag epitope
linked to the N terminus and C terminus of the dihydrofolate
reductase (DHFR) and Mgt1 moieties, respectively]. DUBs co-
translationally cleave this Ub fusion at the UbK48R-Mgt1f junction,
yielding the long-lived reference fDHFR-UbK48R and the test
protein Mgt1f. In this Ub-reference technique (refs. 23 and 25 and
references therein), the free fDHFR-UbK48R serves as a ‘‘built-in’’
reference protein to compensate for scatter of expression levels and
immunoprecipitation efficiency, thereby increasing the accuracy of
pulse–chase assays. The in vivo half-life (t1/2) of Mgt1f at 30 °C was
19 min in wt cells and 32 min in ubr1 cells (Fig. S2A),
consistent with the results of cycloheximide-chase assays (Fig.
S1A), including the residual instability of Mgt1 in ubr1 cells.
We also used the pdr5 S. cerevisiae strain, in which the absence
of the Pdr5 transporter allows the intracellular accumulation of
MG132, a proteasome inhibitor. No Mgt1m13-linked polyUb ‘‘lad-
ders’’ were detected in wt cells in the absence of MG132 (Fig. S1B,
lanes 1 and 2), suggesting that polyubiquitylation of Mgt1 (in
contrast to its subsequent destruction by the proteasome) was
rate-limiting under these conditions. Consistent with this interpre-
tation, larger, presumably polyubiquitylated forms of Mgt1m13
appeared after the treatment of cells for 1 h withMG132 (Fig. S1B,
lanes 1 and 2 versus lanes 3 and 4). The levels of MG132-induced
Mgt1m13 derivatives were much lower in ubr1 cells but were still
detectable (Fig. S1B, lane 4 versus lane 6), suggesting that another
Ub ligase may also target Mgt1. In a different assay, Mgt1ha
(C-terminally ha-tagged) was coexpressed in wt S. cerevisiae with
His6-tagged UbK48R,G76A, a double-mutant Ub that can become a
part of polyUb chains but would inhibit their disassembly by DUBs
(ref. 2 and references therein). S. cerevisiae was treated with
MNNG, and polyubiquitylated proteins were isolated from cell
extracts by using His6-specific chromatography, followed by SDS/
PAGE and IB with anti-ha antibody. A smear of high-Mr, Mgt1ha-
containing proteins was observed near the top of the gel, whereas
such proteins were virtually absent in a test with His6-lacking
UbK48R,G76A (Fig. 2B).
The Ub ligase holoenzyme of the N-end rule pathway is
Ubr1-Rad6, in which the 20-kDa Rad6 is the Ub-conjugating
enzyme (E2) (15, 20). To determine whether other E2s might
also play a role, we carried out cycloheximide-chase assays with
a collection of E2-null mutants that expressed Mgt1f3 (wt Mgt1
C-terminally tagged with 3 copies of the flag epitope). Mgt1f3
was strongly stabilized only in rad6 cells (Fig. S1D, lanes 5 and
6). In addition to being the E2 of the Ubr1 E3, Rad6 also
functions as a part of Ub ligases that contain, in particular, the
Bre1, Ubr2, or Rad18 E3s (34). In cycloheximide-chase assays
with null mutants in these E3s, Mgt1 was significantly stabilized
only in ubr1 cells (Fig. 2D). Interestingly, the degradation of
Mgt1 was accelerated in a ubr2 strain, compared with its wt
counterpart (Fig. 2D, lanes 5 and 6; compare with lanes 1 and 2).
Ubr2 is a sequelog of Ubr1 that also functions in a complex with
Fig. 1. The N-end rule pathway, the UFD pathway, and cotargeting of the
Mgt1 DNA alkyltransferase by these proteolytic systems. (A) The S. cerevisiae
N-end rule pathway. N-terminal residues are indicated by single-letter abbre-
viations for amino acids. Yellow ovals denote the rest of a protein substrate.
Primary, secondary, and tertiary denote mechanistically distinct subsets of
destabilizing N-terminal residues. Hemin (Fe3-heme) inhibits the arginyla-
tion activity of the ATE1-encoded Arg-tRNA-protein transferase (R-
transferase), and also inhibits a subset of Ubr1 functions (24). Reactions in the
shaded rectangle are a part of the pathway that is active in multicellular
eukaryotes, which produce NO (18), and is also relevant to eukaryotes such as
S. cerevisiae, which lackNO synthases but can produceNOby other routes and
can also be influenced by NO from extracellular sources. C* denotes oxidized
Cys, either Cys-sulfinate or Cys-sulfonate. (B) The S. cerevisiae UFD pathway.
Previously known artificial (engineered) UFD substrates have in common a
‘‘nonremovable’’ N-terminal Ub moiety, which functions as a degron in the
UFD pathway (14, 26, 27). Mgt1 is the first physiological UFD substrate that
lacks an N-terminal Ub moiety and is not a component of the Ub system (see
Introduction). A question mark denotes the expectation of other UFD sub-
strates. (C) Cotargeting of Mgt1 by the N-end rule and UFD pathways.
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Rad6. However, in contrast to Ubr1, Ubr2 does not recognize
N-degrons (35). The enhancement of Mgt1 degradation in ubr2
cells (Fig. 2D and Fig. S2B) could be caused by an increased level
of Ubr1-accessible Rad6, and also, nonalternatively, by an
up-regulation of the proteasome, owing to an increase in Rpn4,
which is partially stabilized in ubr2 cells (35, 36).
Either MNNG or High Temperature Accelerate Mgt1 Degradation. At
approximately 200 molecules per haploid cell in exponential cul-
tures, the endogenous Mgt1 is a scarce protein in S. cerevisiae (12).
Mgt1-dependent DNA-alkyltransferase activity in S. cerevisiae ex-
tracts was strongly decreased after a treatment of cells withMNNG
or shifting them from 30 °C to 37 °C (12). Our results account for
these effects, as the in vivo degradation of Mgt1 was accelerated by
these treatments (Fig. 2E and Fig. S2C). Strong effects of increased
temperature on Mgt1 degradation could be detected by either
cycloheximide-chase or conventional pulse–chase assays (Fig. 2 C
and F and Figs. S1E and S2C). In contrast, oxidizing agents such as
H2O2 (Fig. S2C) or t-butyl hydroxide (data not shown) did not
increase the rate of Mgt1 degradation. The acceleration of yeast
Mgt1 degradation by MNNG (Fig. 2E) was analogous to the
previously observed effects of either MNNG or O6-benzylguanine
(the latter alkylates the active-siteCys ofMgmt) on the degradation,
by an unknown pathway, of Mgmt, the mammalian counterpart of
Mgt1 (9). We also examined mgt1 cells that expressed either
Mgt1f3, Mgt1C151M,f3, or Mgt1C151S,f3. In the latter derivatives of
Mgt1, the active-site Cys151 was replaced either by Met, a mimic of
methylated Cys, or by Ser, a substitution that also inactivates Mgt1.
S. cerevisiae expressing Mgt1C151M,f3 or Mgt1C151S,f3 were hypersen-
sitive to MNNG (Fig. 2G). In the absence of MNNG, Mgt1C151M,f3
was much shorter-lived than wt Mgt1f3 (data not shown). By
contrast, and in agreement with the inability of the Ser-mutant
Mgt1C151S,f3 to be alkylated at position 151, this mutant was
longer-lived than wt Mgt1f3 in cells that were treated with MNNG
(Fig. 3A).
The 3D structure of the 22-kDa human MGMT (6), a counter-
part of the 21-kDa S. cerevisiaeMgt1, showed that MGMT consists
of a ‘‘ribonuclease-like’’ N-terminal domain (residues 6–92) and a
C-terminal DNA-binding domain (residues 96–176) (Fig. S3 A, B,
and D). A putative 3D structure of S. cerevisiaeMgt1 was modeled
on human MGMT and took into account its sequelogy to Mgt1
(Fig. S4C). The active-site Cys of human MGMT resides between
the C-terminal DNA-binding domain and the N-terminal lobe that
faces away from DNA (6) (Fig. S3B). Our findings (see Fig. S4A)
indicate that the degron of S. cerevisiae Mgt1 is close to its N
terminus. Thus, the active-site Cys151 of Mgt1 is not a part of its
degron per se. Instead, the alkylation of Cys151 that accompanies
the repair of alkylated DNA by Mgt1 may change its conformation
and/or conformational mobility and thereby increase the accessi-
bility of its degron (which would be expected to ‘‘face away’’ from
DNA) to cognate Ub ligases. This model is consistent with the
above-mentioned faster degradation of Mgt1C151M,f3, which con-
tains Met151, a mimic of methylated Cys, instead of wt Cys151.
The absence of Ubr1 made S. cerevisiae10-fold more resistant
to MNNG, compared with wt cells (Fig. 2H and Fig. S2E). These
results suggested that Ubr1 targets not only alkylated (inactive)
Mgt1 but also unmodifiedMgt1. This interpretation would account
for the higher MNNG resistance of ubr1 cells, as the absence of
degradation of unmodifiedMgt1would result inmore of it available
for DNA repair. In agreement with the hyperresistance of ubr1
cells to MNNG, they were also found to exhibit a lower frequency
of MNNG-induced mutations (Fig. S2D).
Ubr1 Targets Mgt1 Via a Degron Near Its N Terminus. C-terminally
truncated fragments ofMgt1f3 were expressed in either ubr1 or wt
S. cerevisiae, followed by SDS/PAGE of cell extracts and IB with
Fig. 2. Mgt1 as a physiological substrate of the N-end
rule pathway. (A) CHY108, a ubr1 strain of S. cerevisiae
that expressedMgt1m13 (Mgt1 C-terminally taggedwith
13 myc epitopes) (see SI Materials and Methods and
Table S1) was transformed with pRS315 (vector alone),
with pCH100 (expressing wt Ubr1), or with pCH159 (ex-
pressing inactiveUbr1C1220S) (20).Culturesweregrownto
an A600 of1 in SDmedium, followed by a ‘‘chase’’ with
cycloheximide for 1 h and IB of cell extracts with either
anti-myc or anti-tubulin antibodies (the latter antibody
was used to verify the uniformity of total protein loads).
(B) PolyubiquitylatedMgt1ha,detectedby IBwithanti-ha
antibody, in MNNG-treated cells that expressed un-
tagged Ub (lane 1) or His6-Ub (lane 2). Dots on the left
refer to positions of molecular mass markers, at 75, 100,
150,and250kDa, respectively. (C)S. cerevisiaeexpressing
Mgt1f3 (pCH437)orMgt1C151S,f3 (pCH438) (TableS2)were
grown in SDmedium to an A600 of0.8, then incubated
further for 1 h at 30 °Cor 37 °C and labeledwith [35S]me-
thionine/cysteine for 5min, followedbya chase for 0, 20,
and 40 min at 30 °C or 37 °C, respectively. Cell extracts
were precipitated with anti-flag antibody, followed by
SDS–4–12% NuPAGE and autoradiography. (D) Cyclo-
heximide ‘‘chase’’ assayswithMgt1 and S. cerevisiae null
mutants in genes encoding the indicated E3 Ub ligases.
(E) Wt and ubr1 S. cerevisiae expressing Mgt1m13
(Mgt1myc13) from the PMGT1 promoter were grown to an
A600 of0.6 and incubated further in the presence of 68
MMNNG for 1 h, followed by a ‘‘chase’’ with cyclohex-
imide for20and40min, SDS–4–12%NuPAGEofcell extracts, and IBwithanti-mycandanti-tubulinantibodies. (F)Quantitationof thedata inC, usingPhosphorImager.
Openand solid circles indicateMgt1f3 at 37 °Candat 30 °C, respectively; open triangles indicateMgt1C151S,f3 at 37 °C. (G) CHY21 (mgt1) S. cerevisiaeexpressingMgt1f3
(pCH336),Mgt1C151S,f3 (pCH337), orMgt1C151M,f3 (pCH338)were grown to anA600 of0.8 at 30 °C in SDmedium, followedby a further incubation for 1 h, in either the
presence or absence of 68MMNNG. The cultures were serially diluted, spotted on YPD plates, and incubated for 3 days at 30 °C. (H) Colony assay forMNNG toxicity.
S. cerevisiae YPH277 (wt) (solid circles) and YPH277HR1 (ubr1) (open circles) were grown in YPDmedium at 30 °C to an A600 of1.0 andwere further incubated for
1 h in the presence of MNNG at indicated concentrations. Cell suspensions were diluted in PBS, spread on YPD plates, and incubated for 3 days at 30 °C, followed by
determination of colony numbers.
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anti-flag antibody (Fig. S4A). Mgt11–100,f3, which contained the
ribonuclease-like N-terminal domain ofMgt1 but lacked the active-
site Cys151, was undetectable in wt cells but readily detectable in
ubr1 cells (Fig. S4A, lanes 5 and 6), indicating the presence of a
Ubr1-specific degron in the N-terminal half of Mgt1. The results
withMgt11–144,f3 (Fig. S4A, lanes 3 and 4) were similar to those with
Mgt11–100,f3. Mgt184–188,f3, an N-terminally truncated Mgt1, could
not be expressed at detectable levels in either wt or ubr1 cells (Fig.
S4A, lanes 7 and 8).
UFD and N-End Rule Pathways Cotarget Mgt1 for Degradation.Given
the residual instability of Mgt1 in the absence of Ubr1 (Fig. 2 A,
D, and E), we attempted to identify another E3 that may target
Mgt1. This search involved expression of the Mgt11–100,f3 frag-
ment from the PMGT1 promoter (Fig. S4A) and a set of S.
cerevisiae mutants in several E3s (ubr1, ubr2, hrd1, hrd3,
doa10, ufd2, tul1, hul4, hul5, ufd4, tom1, rps5-1ts).
Among thesemutants, theMgt11–100,f3 fragment was significantly
stabilized in ubr1 cells (as expected), and also, remarkably, in
ufd4 cells (Fig. 3B, lane 3). Ufd4 is a 168-kDa HECT-domain
E3 Ub ligase that mediates the UFD pathway (see Introduction
and Fig. 1B). Given this result, we carried out cycloheximide-
chase assays with wt, ubr1, and ubr1 ufd4 double-mutant
S. cerevisiae strains that expressed full-length Mgt1m13. The
absence of both Ubr1 and Ufd4 stabilized Mgt1 much more than
the absence of Ubr1 alone (Fig. 3C and Fig. S2F). The syner-
gistically enhanced stabilization of Mgt1m13 in ubr1 ufd4 cells
was observed either at 37 °C (Fig. S2F) or upon a treatment with
MNNG (Fig. 3C). Moreover, a conventional pulse–chase assay
at 37 °C with Mgt1f3 and either wt, ubr1, or ubr1 ufd4 cells
has demonstrated a virtually complete stabilization of newly
formed Mgt1 in ubr1 ufd4 cells (Fig. 3 D and E). As would be
expected (given the results above), the absence of Ufd4 alone
partially stabilized Mgt1, especially in ufd4 versus wt cells that
were treated with MNNG (Fig. S2 G and H).
S. cerevisiae lacking Ufd4 were 2.5-fold more resistant to
MNNG than their wt counterparts (Fig. 3F and Fig. S4F). Double-
mutant ubr1 ufd4 cells, in whichMgt1 was particularly long-lived
(Fig. 3 C–E), grew slightly slower than congenic wt cells (Fig. S4 F
andG and data not shown). Moreover, overexpressing of Mgt1f3 in
either wt, ubr1, or ufd4 cells did not significantly impair their
growth (data not shown) but led to a severe growth defect in ubr1
ufd4 cells (Fig. S4 G and H). Thus, the inability to destroy Mgt1
is near-lethal upon overexpression of Mgt1 and is also likely to be
deleterious, to a lower extent, at physiological levels of Mgt1.
In Vitro Binding of Ubr1 and Ufd4 to Mgt1 and Cup9. The type 1 and
type 2 substrate-binding sites of Ubr1 are specific for basic N-
terminal residues (Arg, Lys,His) and bulky hydrophobicN-terminal
residues (Trp, Phe, Tyr, Leu, Ile), respectively. The third binding
site of Ubr1 recognizes an internal (non-N-degron) degradation
signal of Cup9, a transcriptional repressor of a regulon that includes
the Ptr2 transporter of di- and tripeptides (19, 22, 25). This binding
site ofUbr1 is autoinhibited but can be allosterically activated by the
binding of cognate peptides (including those imported into cells by
Ptr2) to the type 1/2 sites of Ubr1. The resulting down-regulation
of the Cup9 repressor, through its accelerated degradation by the
N-end rule pathway, up-regulates the expression of the Ptr2 trans-
porter. This positive-feedback circuit allows S. cerevisiae to detect
the presence of extracellular peptides and to react by increasing
their uptake (22, 23, 25). We used cup9, ubr1, and cup9 ubr1
mutants to determine whether the observed effect of Ubr1 on the
in vivo degradation of Mgt1 (e.g., Fig. 2 A, B, D, and F) might be
influenced by a circuit controlled by Cup9, and found no such
influence (Fig. S4E).
In agreement with previous work, which used GST-pulldown
assays to demonstrate the dependence of interactions between
Ubr1 and GST-Cup9 on the presence of cognate (type 1/2) dipep-
tides (19, 22), the in vitro binding of fUbr1 to GST-Cup9 required
the presence of cognate dipeptides such as Arg-Ala (type 1 dipep-
Fig. 3. TheUFDpathway plays a role in degradation of
Mgt1. (A) CHY21 (mgt1) S. cerevisiae expressingMgt1f3
(pCH336), Mgt1C151S,f3 (pCH337), or Mgt1C151M,f3
(pCH338) were grown to an A600 of 0.8 at 30 °C, then
incubated for 1 h with MNNG at 68 M, followed by a
‘‘chase’’ with cycloheximide for 15 and 30 min, SDS–4–
12% NuPAGE of cell extracts, and IB with anti-flag and
anti-tubulin antibodies. (B) The in vivo levels of MGT11–
100,f3 (see Fig. S4A) were compared by IB, using anti-flag
andanti-tubulinantibodies (the lattera loadingcontrol),
with extracts fromwt S. cerevisiae and its nullmutants in
either Ubr1 or several HECT-type E3 Ub ligases (a tsmu-
tant in the case of Rps5). MGT11–100,f3 was expressed in
these strains from pCH372 (Table S2). Cultures were
grown at 30 °C to an A600 of 0.8. Some IB assays (with
rps5-1 cells) were also carried outwith extracts from cells
that were incubated for 1 h at 37 °C. Note an increase of
MGT11–100,f3 in ufd4 cells, in addition to ubr1 cells. (C)
Wt, ubr1, and ubr1 ufd4 S. cerevisiae that expressed
chromosomally integrated MGT1m13 (see SI Materials
andMethods)weregrownat30 °CtoanA600of0.8and
werefurther incubated inthepresenceofMNNG(68M)
for 1 h, followed by a ‘‘chase’’ with cycloheximide for 20
and 40min, SDS–4–12%NuPAGE of cell extracts, and IB
with anti-myc and anti-tubulin antibodies. (D) Pulse–
chase assayswithMgt1f3 andwt (lanes 1–3),ubr1 (lanes
4–6), or ubr1 ufd4 (lanes 7–9) S. cerevisiae. Cells ex-
pressingMgt1f3 from the PMET25 promoter on a low copy
plasmid were labeled for 5 min with [35S]methionine/
cysteine and chased for 0, 20, or 40 min, followed by immunoprecipitation with anti-flag antibody, SDS/PAGE, and autoradiography (see SI Materials andMethods).
(E)Quantitationofdata inD, usingPhosphorImager. Circles,wt cells; triangles,ubr1 cells; squares,ubr1ufd4 cells. 100%refers to the relative amountof 35S at time
0 (end of pulse) for each of 3 pulse–chases. (F) S. cerevisiae of the indicated genotypes were grown to an A600 of0.6 in YPDmedium andwere further incubated in
either the presence or absence ofMNNG (0.34mM) for 1.5 h at 30 °C. Cell suspensions were dilutedwith PBS (PBS), spread on YPD plates, and incubated for 3 days at
30 °C. Survival refers to numbers of colonies in MNNG-treated samples as percentages of the corresponding numbers in untreated samples.
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tide) and Leu-Ala (type 2 dipeptide) (Fig. S4B, lane 11; compare
with lane 12). Analogous GST pulldowns were used to detect a
specific interaction between fUbr1 and GST-Mgt1 (Fig. S4B, lanes
3–9). Interestingly, this interaction did not require the presence of
cognate dipeptides. Moreover, it was inhibited by the same (cog-
nate) dipeptides at concentrations that activated the interaction of
fUbr1 with GST-Cup9 (Fig. S4B, lane 8, compare with lanes 3 and
9). The comparably robust but opposite effect of cognate peptides
on the Ubr1-Mgt1 interaction remains to be understood in physi-
ological terms.
As would be expected from the Ufd4-dependent degradation
of Mgt1 in vivo (Fig. 3 B–E and Fig. S2 G and H), a GST-Mgt1
pulldown with haUfd4 (instead of fUbr1) confirmed the binding
of Ufd4 to Mgt1 (Fig. S4C). In contrast to Mgt1-Ubr1 interac-
tions, which were inhibited by cognate type 1/2 dipeptides (Fig.
S4B), the binding of haUfd4 to GST-Mgt1 occurred irrespective
of type 1/2 or other tested dipeptides (Fig. S4C). The same
results were obtained with Mgt1-GST, in which the GST moiety
was C-terminal rather than N-terminal (data not shown). The
Ufd4-Mgt1interaction could also be detected by using a coim-
munoprecipitation assay (Fig. S4D).
Synergistic Enhancement of the Extent and Processivity of Mgt1
Polyubiquitylation by Ubr1 and Ufd4. We developed an in vitro
system that consisted of the following purified components: Ub;
Uba1 (Ub-activating enzyme, E1); Rad6 and/or Ubc4 (E2 enzymes
specific for Ubr1 and Ufd4, respectively); Ubr1 and/or Ufd4 (E3s
that targetMgt1); and ATP. This system also contained 35S-labeled
Mgt1f3, which was produced in reticulocyte lysate (see SI Materials
andMethods). In the final reactionmix, 10%of the total volumewas
contributed by the 35S-Mgt1-containing reticulocyte lysate. Either
the Ubr1-Rad6 Ub ligase alone or the Ufd4-Ubc4 Ub ligase alone
polyubiquitylatedMgt1 in vitro (Fig. 4, lanes 3 and 5; compare with
lane 1). Whereas the yield of polyubiquitylated Mgt1 was higher
with Ubr1-Rad6 alone than with Ufd4-Ubc4 alone, the latter Ub
ligase was more processive. Specifically, Mgt1 that was polyubiq-
uitylated by Ufd4-Ubc4 alone migrated as a set of derivatives in a
relatively narrow size range, 180 kDa. This molecular mass
implied the presence of a polyUb chain linked to the 21-kDa Mgt1
and containing 19 Ub moieties (Fig. 4, lane 5). In contrast, the
polyubiquitylatedMgt1 produced by Ubr1-Rad6 alone migrated as
a more diffuse set of derivatives, and at a significantly lower size
range, up to150 kDa (Fig. 4, lanes 3 and 5; compare with lane 1).
Strikingly, the polyubiquitylation of Mgt1 in the presence of
Ubr1-Rad6 andUfd4-Ubc4 together exhibited both a higher overall
yield and higher processivity. Specifically, Mgt1 that was polyubiq-
uitylated in the presence of both the N-end rule’s and UFD’s Ub
ligases migrated as a set of higher-yield derivatives in a relatively
narrow size range, 200 kDa on average (Fig. 4, lane 6; compare
with lanes 3 and 5). This sizewas higher than the onewithMgt1with
Ufd4-Ubc4 alone (Fig. 4, lane 5) andmuch higher than the onewith
Mgt1 with Ubr1-Rad6 alone (Fig. 4, lane 3; compare with lane 1).
This reproducible result (Fig. 4, lane 6, and data not shown)
indicated that the targetingmechanisms of theN-end rule andUFD
pathways are not simply ‘‘additive’’ in regard to Mgt1. Specifically,
this cotargeting of Mgt1, reconstituted in the in vitro system, is
synergistic both in regard to yields of polyubiquitylatedMgt1 and in
regard to the processivity of polyubiquitylation (Fig. 4, lanes 1, 3, 5,
and 6). Operationally, the Ufd4-Ubc4 Ub ligase appears to func-
tion, in part, as an enhancer of the processivity of Mgt1 polyubiq-
uitylation by Ubr1-Rad6 (Fig. 4). Such a role of Ufd4-Ubc4 may be
analogous to the function of Ufd2, a component of the UFD
pathway that Jentsch and colleagues showed to act by increasing the
processivity of polyubiquitylation of UFD substrates that contain
the N-terminal Ub moiety (28).
Concluding Remarks. The discovery that Mgt1, the DNA alkyltrans-
ferase of S. cerevisiae, is a physiological substrate of both the N-end
rule pathway and the UFD pathway (Fig. 1C) has ramifications for
the control of DNA repair not only in fungi but in other eukaryotes
as well. The AGT proteins (see Introduction), including yeast Mgt1
and mammalian Mgmt (MGMT), are highly sequelogous (Fig.
S3D). In addition, the N-end rule and UFD pathways are present
in all eukaryotes examined (2, 14, 26–29, 33).Using a split-Ub assay,
we found that mouse Ubr1 and Ubr2, 2 sequelogous N-recognins
of the mammalian N-end rule pathway, interact with mouse Mgmt
in vivo (J. Sheng, C.-S. H., and A. V., unpublished data), strongly
suggesting that (at least) the N-end rule pathway mediates the
degradation of mammalian Mgmt. Mouse Ubr2/ fibroblasts,
which lack Ubr2 and therefore contain a partially impaired N-end
rule pathway, were found to be hypersensitive to mitomycin C, a
DNA cross-linking agent (37). Melanoma cells that overexpress
Mgmt are also hypersensitive to mitomycin C (38). Taken together
with our results (Fig. 1C), these findings suggest that the degrada-
tion of mammalian Mgmt, presumably by both the N-end rule and
UFD pathways, plays a role in determining the sensitivity of
mammalian cells to alkylating agents, including some DNA cross-
linking agents as well. The striking effect of simultaneous presence
of the Ubr1-Rad6 and Ufd4-Ubc4 Ub ligases on both the yield and
processivity of Mgt1 polyubiquitylation makes the in vitro system
described in Fig. 4 a promising tool for further analyses of Mgt1
targeting. It should be possible to make this assay better defined
through the provision of purified Mgt1, currently the system’s sole
unpurified component (Fig. 4). Questions that can be addressed by
this approach include specific location(s) and topology of Mgt1-
linked polyUb chains that are produced by the Ubr1-Rad6 versus
Ufd4-Ubc4 Ub ligases.
The in vivo destruction of Mgt1 that had become alkylated
(through the repair of alkylatedDNAbyMgt1)may occur at or near
the sites of repaired DNA lesions. A priori, it is likely (nothing is
known about this at present) that Mgt1 functions as a part of
chromosome-associated protein complexes. If so, the subunit se-
Fig. 4. Synergistic cotargeting of Mgt1 by the N-end rule and UFD pathways.
The invitroubiquitylation systemcontained:Ub (80M),Uba1 (E1,Ub-activating
enzyme, 0.1M),Rad6andUbc4 (E2,Ub-conjugatingenzymes, 1Meach),Ubr1
and Ufd4 (E3 Ub ligases, 0.2 Meach) were purified proteins. 2 l of 35S-labeled
Mgt1, produced by using the TNT T7 Quick for PCR DNA and 4 mM ATP (see SI
Materials andMethods),wereaddedto theabove reactionmixture (final volume
20l) or its variations, as indicated in the image, followed by incubation at 30 °C
for 15 min. One half of each sample was fractionated by SDS–4–12% NuPAGE,
followedby autoradiography. 35S-Mgt1 and its polyubiquitylatedderivatives are
indicated on the right. Lane 1, S35-Mgt1 (input). Lane 2, same as lane 1 but with
Rad6. Lane 3, same as lane 1 but with Ubr1 and Rad6. Lane 4, same as lane 1 but
with Ubc4. Lane 5, same as lane 1 but with Ufd4 and Ubc4. Lane 6, same as lane
1 butwithUbr1, Rad6, Ufd4, andUbc4. Lane 7, same as lane 6 butwithout Ubc4.
Lane 8, same as lane 6 but without Rad6. Note a strikingly synergistic enhance-
ment of Mgt1 polyubiquitylation, including an increase in the mean size of
Mgt1-conjugated polyUb chains in the presence of both Ubr1/Rad6 and Ufd4/
Ubc4 (lane 6).
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lectivity of the N-end rule pathway, i.e., its ability to remodel a
protein complex by destroying a subset of its subunits while sparing
the rest of them (39), might play a role in the in vivo degradation
of Mgt1. This process may be analogous to the previously discov-
ered selective degradation, by the N-end rule pathway, of the
separase-produced fragment of Scc1, a subunit of chromosome-
associated cohesin complexes (40). This degradation of the Scc1
fragment is essential for the high fidelity of chromosome segrega-
tion (40). Both the alkylated (inactive) Mgt1 protein (Fig. 1C) and
the separase-produced fragment of the Scc1 cohesin subunit (40)
are obligatory in vivo products of the corresponding circuits. These
proteins are also ‘‘dead-end’’ structures. Under conditions where
the Scc1 fragment cannot be eliminated by the N-end rule pathway,
this protein can be shown to perturb chromosome mechanics (40).
A chromosome-bound, alkylated but unremovedMgt1may present
an analogous problem. Thus, the N-end rule and UFD pathways
operate, in these contexts, as homeostasis-maintaining devices that
employ their capacity for subunit-selective protein remodeling (39)
to reset the states of relevant circuits. Because ubr1, ufd4, and
particularly ubr1 ufd4 cells were hyperresistant (rather than
hypersensitive) to the toxicity of MNNG (Fig. 3F), a precise role of
the N-end rule and UFD pathways vis-a-vis DNA repair and other
cellular functions remains to be understood. For example, a ho-
meostatic role of these pathways in removing, through degradation,
the alkylated (chromosome-bound?) Mgt1 may be important not
for the repair of alkylated DNA per se but for another chromo-
some-associated process(es) that would be either halted or function
suboptimally in the presence of unremoved Mgt1. This interpreta-
tion is consistent with a strong toxicity of overexpressed Mgt1 in
ubr1 ufd4 cells but not in wt cells (Fig. S4 G and H).
The discovery that Mgt1 is cotargeted by 2 otherwise dissimilar
Ub-dependent pathways (Fig. 1) opens up new questions. For
example:Might the cotargeting ofMgt1 byUbr1 andUfd4 (Fig. 1C)
signify a physical interaction between these E3s? Our preliminary
data suggest that Ubr1 and Ufd4 indeed interact, possibly in a
conditional manner (unpublished data). Furthermore, previous
work indicated that the both the Ubr1 and Ufd4 E3s interact with
specific subunits of the 26S proteasome (30, 31). Thus, the dem-
onstrated cotargeting ofMgt1 by theN-end rule andUFDpathways
(Fig. 1C) may involve not only copolyubiquitylation of Mgt1 (Fig.
4) but proteasome-docking steps as well.
Methods
For descriptions of materials and methods, including S. cerevisiae strains, plas-
mids, and PCR primers, see SIMaterials andMethods and Tables S1–S3. Standard
techniques, including PCR, were used to construct specific plasmids and yeast
strains. Specific protein components of the polyubiquitylation assay (Fig. 4)were
expressed in S. cerevisiae or Escherichia coli and purified by affinity chromatog-
raphy. Theepitope-taggedderivatives ofMgt1,Ubr1 andUfd4were constructed
using standard methods (see SI Materials and Methods), and were used in
immunoblotting, coimmunoprecipitation, cycloheximide-chase, pulse–chase,
GSTpulldown,andeither in vivoor in vitropolyubiquitylationassayswithMgt1and
itsderivatives. Theseproceduresandtechniques, including specificassays for toxicity
andmutagenicity of MNNG, are described, in detail, in SI Materials andMethods.
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